Evidence indicates that high sensitivity C-reactive protein (Hs-CRP) may be associated with the metabolic variables and predictors of cardiovascular risk in T2DM with and without nephropathy [260,261]. This evidence concerns the gene CRP and type 2 diabetes mellitus.